Skip to content

Effect of dexmedetomidine administered for postoperative analgesia on the incidence postoperative nausea and vomiting after gynaecological laparoscopic surgery: a randomized controlled trial

Effect of dexmedetomidine administered for postoperative analgesia on the incidence postoperative nausea and vomiting after gynaecological laparoscopic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017172
Enrollment
Unknown
Registered
2018-07-16
Start date
2018-07-23
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

dexmedetomidine (Dex) group:Patient-controlled intravenous analgesia is established with 100 ml of 0.5 mg/ml morphine plus 1 µg/ml dexmedetomidine.
control (Ctrl) group:Patient-controlled intravenous analgesia is established with 100 ml of 0.5 mg/ml morphine

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Adult female patients aged between 18 and 65 years old; (2) Scheduled to undergo elective gynaecological laparoscopic surgery (myomectomy,hysterectomy and radical resection of endometrial carcinoma); (3) Preoperative American Society of Anaesthesiologists physical status I~II.

Exclusion criteria

Exclusion criteria: (1) Refuse to participate in the trial; (2) History of schizophrenia, epilepsia, Parkinson's Disease or myasthenia gravis; (3) Unable to communicate due to coma, severe dementia or language barrier; (4) Obesity (BMI>30kg/m 2); (5) Preoperative LVEF<30%, sick sinus syndrom, severe sinus bradycardia(heart rate<50bpm) or atrioventricular block at least II without pacemaker; (6) Preoperative severe hepatic disease (Child-pugh grade C or above); (7) Preoperative chronic renal failure (need dialysis); (8) Use of antiemetics , psychotropic drugs, opioids, antihistamine or glucocorticoids within 24 h before surgery; (9) Preoperative radiochemotherapy; (10) Pregnancy or breastfeeding or plan to be pregnancy; (11) Other reasons not suitable for participating.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative nausea and vomiting;PONV intensity scale;

Secondary

MeasureTime frame
VAS pain score;PCIA use and additional dose of analgesic;

Countries

China

Contacts

Public ContactGeng Zhiyu

Peking University First Hospital

gengzhiyu2013@163.com+86 13681121461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026